Serge Saxonov - 22 Feb 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
22 Feb 2022
Net transactions value
-$43,309
Form type
4
Filing time
24 Feb 2022, 18:39:35 UTC
Previous filing
10 Feb 2022
Next filing
24 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $43,309 -551 -0.06% $78.60 912,742 22 Feb 2022 Direct F1
holding TXG Class A Common Stock 4,138 22 Feb 2022 See footnote F2
holding TXG Class A Common Stock 89,960 22 Feb 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.